NEW YORK, Aug. 19 (GenomeWeb News) -- Perlegen has won a grant from the National Institute of Mental Health to study the genetics of autism, the company said today.
Perlegen will assay DNA samples collected by the Autism Genetic Resource Exchange for single nucleotide polymorphisms from its collection of validated SNPs. The company aims to identify genetic variants that, in combination, contribute to the inheritability of autism.
MountainView, Calif.-based Perlegen is a spin-off from Affymetrix.